Nuwellis, Inc. (NUWE) DCF Valuation
- ✓ Totalmente Editável: Adapte-Se Às Suas Necessidades No Excel Ou Planilhas
- ✓ Design Profissional: Modelos Confiáveis E Padrão Da Indústria
- ✓ Pré-Construídos Para Uso Rápido E Eficiente
- ✓ Não É Necessária Experiência; Fácil De Seguir
Nuwellis, Inc. (NUWE) Bundle
Streamline your analysis and improve precision with our [NUWE] DCF Calculator! Utilizing real data from Nuwellis, Inc. and customizable assumptions, this tool empowers you to forecast, evaluate, and appraise [Company] like a seasoned investor.
Discounted Cash Flow (DCF) - (USD MM)
Year | AY1 2019 |
AY2 2020 |
AY3 2021 |
AY4 2022 |
AY5 2023 |
FY1 2024 |
FY2 2025 |
FY3 2026 |
FY4 2027 |
FY5 2028 |
---|---|---|---|---|---|---|---|---|---|---|
Revenue | 5.5 | 7.4 | 7.9 | 8.5 | 8.9 | 10.0 | 11.4 | 12.9 | 14.6 | 16.5 |
Revenue Growth, % | 0 | 35.02 | 6.45 | 7.85 | 3.76 | 13.27 | 13.27 | 13.27 | 13.27 | 13.27 |
EBITDA | -17.9 | -16.7 | -19.1 | -4.9 | -16.4 | -9.2 | -10.4 | -11.8 | -13.3 | -15.1 |
EBITDA, % | -324.21 | -223.79 | -240.59 | -57.32 | -184.52 | -91.46 | -91.46 | -91.46 | -91.46 | -91.46 |
Depreciation | .2 | .4 | .5 | .4 | .4 | .5 | .5 | .6 | .7 | .8 |
Depreciation, % | 4.34 | 5.05 | 6.16 | 4.35 | 4.08 | 4.8 | 4.8 | 4.8 | 4.8 | 4.8 |
EBIT | -18.1 | -17.0 | -19.5 | -5.3 | -16.7 | -9.3 | -10.5 | -11.9 | -13.5 | -15.3 |
EBIT, % | -328.54 | -228.84 | -246.75 | -61.68 | -188.61 | -92.34 | -92.34 | -92.34 | -92.34 | -92.34 |
Total Cash | 1.3 | 14.4 | 24.2 | 18.3 | 3.8 | 7.4 | 8.3 | 9.4 | 10.7 | 12.1 |
Total Cash, percent | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
Account Receivables | .8 | .9 | .8 | 1.4 | 2.0 | 1.5 | 1.7 | 1.9 | 2.2 | 2.5 |
Account Receivables, % | 14.5 | 12.16 | 9.47 | 16.46 | 22.01 | 14.92 | 14.92 | 14.92 | 14.92 | 14.92 |
Inventories | 1.8 | 3.0 | 2.8 | 2.7 | 2.0 | 3.3 | 3.7 | 4.2 | 4.7 | 5.4 |
Inventories, % | 32.61 | 39.74 | 35.89 | 31.15 | 22.53 | 32.38 | 32.38 | 32.38 | 32.38 | 32.38 |
Accounts Payable | 1.5 | 1.1 | 1.4 | 2.2 | 2.4 | 2.3 | 2.6 | 2.9 | 3.3 | 3.7 |
Accounts Payable, % | 27 | 14.74 | 17.85 | 26.28 | 26.85 | 22.54 | 22.54 | 22.54 | 22.54 | 22.54 |
Capital Expenditure | -.5 | -.3 | -.2 | -.1 | -.2 | -.4 | -.5 | -.5 | -.6 | -.7 |
Capital Expenditure, % | -8.89 | -4 | -2.76 | -1.43 | -2.8 | -3.98 | -3.98 | -3.98 | -3.98 | -3.98 |
Tax Rate, % | -0.039602 | -0.039602 | -0.039602 | -0.039602 | -0.039602 | -0.039602 | -0.039602 | -0.039602 | -0.039602 | -0.039602 |
EBITAT | -18.1 | -17.0 | -19.6 | -5.3 | -16.7 | -9.3 | -10.5 | -11.9 | -13.5 | -15.3 |
Depreciation | ||||||||||
Changes in Account Receivables | ||||||||||
Changes in Inventories | ||||||||||
Changes in Accounts Payable | ||||||||||
Capital Expenditure | ||||||||||
UFCF | -19.5 | -18.6 | -18.7 | -4.7 | -16.4 | -10.1 | -10.7 | -12.2 | -13.8 | -15.6 |
WACC, % | 422.33 | 422.33 | 422.33 | 422.33 | 422.33 | 422.33 | 422.33 | 422.33 | 422.33 | 422.33 |
PV UFCF | ||||||||||
SUM PV UFCF | -2.4 | |||||||||
Long Term Growth Rate, % | 2.00 | |||||||||
Free cash flow (T + 1) | -16 | |||||||||
Terminal Value | -4 | |||||||||
Present Terminal Value | 0 | |||||||||
Enterprise Value | -2 | |||||||||
Net Debt | -3 | |||||||||
Equity Value | 1 | |||||||||
Diluted Shares Outstanding, MM | 0 | |||||||||
Equity Value Per Share | 10.74 |
What You Will Get
- Real NUWE Financials: Access to historical and projected data for precise valuation.
- Customizable Inputs: Adjust WACC, tax rates, revenue growth, and capital expenditures as needed.
- Dynamic Calculations: Intrinsic value and NPV are computed automatically.
- Scenario Analysis: Explore various scenarios to assess Nuwellis, Inc.'s future performance.
- User-Friendly Design: Designed for professionals while remaining approachable for newcomers.
Key Features
- 🔍 Real-Life NUWE Financials: Pre-filled historical and projected data for Nuwellis, Inc.
- ✏️ Fully Customizable Inputs: Adjust all critical parameters (yellow cells) like WACC, growth %, and tax rates.
- 📊 Professional DCF Valuation: Built-in formulas calculate Nuwellis’s intrinsic value using the Discounted Cash Flow method.
- ⚡ Instant Results: Visualize Nuwellis’s valuation instantly after making changes.
- Scenario Analysis: Test and compare outcomes for various financial assumptions side-by-side.
How It Works
- Download the Template: Gain immediate access to the Excel-based NUWE DCF Calculator.
- Input Your Assumptions: Modify the yellow-highlighted cells for growth rates, WACC, margins, and additional parameters.
- Instant Calculations: The model automatically recalculates Nuwellis, Inc.'s intrinsic value.
- Test Scenarios: Experiment with various assumptions to assess potential changes in valuation.
- Analyze and Decide: Leverage the results to inform your investment or financial evaluation.
Why Choose This Calculator for Nuwellis, Inc. (NUWE)?
- Designed for Experts: A sophisticated tool utilized by financial analysts, investors, and industry professionals.
- Accurate Data: Nuwellis’ historical and projected financials preloaded for reliable analysis.
- Flexible Scenario Analysis: Easily test various forecasts and assumptions to gauge potential outcomes.
- Comprehensive Outputs: Instantly computes intrinsic value, NPV, and other essential metrics.
- User-Friendly Interface: Step-by-step guidance ensures a smooth experience throughout the calculation process.
Who Should Use Nuwellis, Inc. (NUWE)?
- Healthcare Professionals: Understand innovative treatment options and their impact on patient care.
- Researchers: Integrate advanced technologies into studies on fluid management and patient outcomes.
- Investors: Evaluate market trends and assess the potential of Nuwellis, Inc. (NUWE) within the medical device sector.
- Industry Analysts: Enhance your analysis with comprehensive data on product efficacy and market positioning.
- Medical Practitioners: Discover how Nuwellis, Inc. (NUWE) solutions can improve clinical practices and patient management.
What the Template Contains
- Preloaded NUWE Data: Historical and projected financial data, including revenue, EBIT, and capital expenditures.
- DCF and WACC Models: Professional-grade sheets for calculating intrinsic value and Weighted Average Cost of Capital.
- Editable Inputs: Yellow-highlighted cells for adjusting revenue growth, tax rates, and discount rates.
- Financial Statements: Comprehensive annual and quarterly financials for deeper analysis.
- Key Ratios: Profitability, leverage, and efficiency ratios to evaluate performance.
- Dashboard and Charts: Visual summaries of valuation outcomes and assumptions.